61 related articles for article (PubMed ID: 35734321)
1. Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Harrison DJ; Qumseya A; Xue W; Arnold M; Lautz TB; Hiniker SM; Thomas SM; Venkatramani R; Weiss AR; Mascarenhas L
Pediatr Blood Cancer; 2024 Apr; 71(4):e30847. PubMed ID: 38282125
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and treatment outcomes in patients with pleomorphic rhabdomyosarcoma: a population-based cohort study.
Kobayashi H; Okajima K; Zhang L; Hirai T; Ishibashi Y; Tsuda Y; Ikegami M; Kawai A; Tanaka S
Jpn J Clin Oncol; 2024 Apr; 54(4):471-478. PubMed ID: 38183215
[TBL] [Abstract][Full Text] [Related]
3. Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification.
de Traux de Wardin H; Xu B; Dermawan JK; Smith MH; Wolden SL; Antonescu CR; Wexler LH
JCO Precis Oncol; 2023 Jun; 7(1):e2200705. PubMed ID: 37315267
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic characteristics, treatment, prognosis and pregnancy outcomes in rhabdomyosarcoma of the uterine cervix: a case series.
Yu X; Qie M; Huang L; Hou M
Ginekol Pol; 2023 Dec; ():. PubMed ID: 38126889
[TBL] [Abstract][Full Text] [Related]
5. Embryonal and alveolar rhabdomyosarcoma in adolescents/young adults, adults and older adults: a population-based cohort study.
Kobayashi H; Okajima K; Zhang L; Hirai T; Ishibashi Y; Tsuda Y; Ikegami M; Kawai A; Tanaka S
Jpn J Clin Oncol; 2024 Apr; ():. PubMed ID: 38677984
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and prognosis of embryonal rhabdomyosarcoma in children and adolescents: An analysis of 464 cases from the SEER database.
Wang X; Feng J; Li Z; Zhang X; Chen J; Feng G
Pediatr Investig; 2020 Dec; 4(4):242-249. PubMed ID: 33376951
[TBL] [Abstract][Full Text] [Related]
7. Loss of Chromosome 3q Is a Prognostic Marker in Fusion-Negative Rhabdomyosarcoma.
Dehner CA; Bell RC; Cao Y; He K; Chrisinger JSA; Armstrong AE; Yohe M; Shern J; Hirbe AC
JCO Precis Oncol; 2023 Sep; 7():e2300037. PubMed ID: 37738543
[TBL] [Abstract][Full Text] [Related]
8. Demographic and Treatment Variables Influencing Outcome for Localized Paratesticular Rhabdomyosarcoma: Results From a Pooled Analysis of North American and European Cooperative Groups.
Walterhouse DO; Barkauskas DA; Hall D; Ferrari A; De Salvo GL; Koscielniak E; Stevens MCG; Martelli H; Seitz G; Rodeberg DA; Shnorhavorian M; Dasgupta R; Breneman JC; Anderson JR; Bergeron C; Bisogno G; Meyer WH; Hawkins DS; Minard-Colin V
J Clin Oncol; 2018 Oct; 36(35):JCO2018789388. PubMed ID: 30351998
[TBL] [Abstract][Full Text] [Related]
9. Relapsed Rhabdomyosarcoma.
Heske CM; Mascarenhas L
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671214
[TBL] [Abstract][Full Text] [Related]
10. Embryonal Rhabdomyosarcoma of the Prostate: Clinico-Pathological Highlights with Review of Literature.
Singh A; Phulware RH; Kumar A; Kishore S
J West Afr Coll Surg; 2024; 14(2):225-228. PubMed ID: 38562397
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic pleomorphic rhabdomyosarcoma.
Shirafkan Md A; Boroumand Md N; Komak Md S; Duchini Md A; Cicalese Md L
Int J Surg Case Rep; 2015; 13():33-6. PubMed ID: 26092712
[TBL] [Abstract][Full Text] [Related]
12. Rhabdomyosarcoma.
Skapek SX; Ferrari A; Gupta AA; Lupo PJ; Butler E; Shipley J; Barr FG; Hawkins DS
Nat Rev Dis Primers; 2019 Jan; 5(1):1. PubMed ID: 30617281
[TBL] [Abstract][Full Text] [Related]
13. Adult Laryngeal Pleomorphic Rhabdomyosarcoma: A Rare Entity.
Cai H; Chen S; Zhang ZY; Gao BB; Ding YY; Liu BH; Wang WW
Ear Nose Throat J; 2023 Sep; ():1455613231198986. PubMed ID: 37715691
[TBL] [Abstract][Full Text] [Related]
14. Cervicofacial Rhabdomyosarcoma - Success of a Free Fibular Graft.
Totadri VM; Geetha V; Acharya SK; Narayanan PJ; Palakundan SM; Sugandhi N; Sreedharan A
J Indian Assoc Pediatr Surg; 2024; 29(2):168-170. PubMed ID: 38616842
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological characteristics, treatment outcome and prognostic factors in adult rhabdomyosarcoma: a monocentric retrospective study.
Saadi M; Letaief F; Gabsi A; Mokrani A; Meddeb K; Mezlini A
Pan Afr Med J; 2022; 41():246. PubMed ID: 35734321
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
17. Prognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment.
Liu YT; Wang CW; Hong RL; Kuo SH
Anticancer Res; 2019 Mar; 39(3):1355-1364. PubMed ID: 30842169
[TBL] [Abstract][Full Text] [Related]
18. Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study.
Bompas E; Campion L; Italiano A; Le Cesne A; Chevreau C; Isambert N; Toulmonde M; Mir O; Ray-Coquard I; Piperno-Neumann S; Saada-Bouzid E; Rios M; Kurtz JE; Delcambre C; Dubray-Longeras P; Duffaud F; Karanian M; Le Loarer F; Soulié P; Penel N; Blay JY
Cancer Med; 2018 Aug; 7(8):4023-4035. PubMed ID: 29956493
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and long-term outcomes of rhabdomyosarcoma in Korean children, adolescents and young adults: a single-center experience.
Park M; Lee JA; Jin HY; Kim JY; Park JW; Kim JH; Kang HG; Park SY; Park EY; Park HJ; Park BK
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3109-3119. PubMed ID: 35870013
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
